Background
Congenital cataracts (CCs) are now the most common avoidable cause of childhood blindness worldwide, accounting for 10–35% of such cases, with an estimated incidence of 0.63–9.14/10,000 births [
1‐
4]. Management is often difficult due to the risk of amblyopia in the developing visual system and complications of glaucoma, posterior synechia or visual axis opacification, which require additional surgery [
5]. CCs occur due to the disruption of the lens microarchitecture or the protein function in the lens [
6]. Except for a very few infectious cases, only one-third of CC cases have a positive family history [
7], with the other two-thirds having an unknown aetiology [
8]. Therefore, a significant proportion are sporadic cases in which it is not known whether there is an underlying genetic cause for the lens abnormality.
Thus far, approximately 350 genes have been reported to be associated with CC (Cat-Map;
http://cat-map.wustl.edu/); these include mutations in crystallins and gap junction, membrane transport and channel, and cytoskeletal proteins and growth and transcription factors [
9]. Locating and identifying the involved genes and mutations are essential to gaining an understanding of the molecular defects and pathophysiologic characteristics underlying inherited CC.
A conventional approach to identifying mutations in CC is usually performed by Sanger sequencing only in familial cases and is time-consuming and costly, with a detection rate of 30–50% in apparent autosomal dominant cases [
10,
11]. Due to marked genetic and phenotypic heterogeneity, determining the precise genetic cause of CC and establishing a robust genotype-phenotype correlation is challenging. Next-generation DNA sequencing (NGS) is increasingly powerful as a diagnostic tool and offers speed, precision, and cost-effectiveness for heterogeneous conditions [
12]. This has been demonstrated in studies to determine the cause of other heterogeneous inherited eye diseases, such as congenital macular dystrophy and retinal pigmentosa [
13‐
16]. Recent studies have also shown that NGS allows the efficient identification of genetic causes of CC in the majority of cases, thereby improving its diagnosis and clarifying inheritance patterns [
17‐
19] while guiding genetic counselling and increasing prognostic accuracy.
In this study, we applied targeted NGS in 792 genes involved in common inherited eye diseases to detect causal mutations in a relatively large series of CCs, including a high proportion of sporadic cases, and report the different distributions of mutated genes in sporadic versus familial CC cases (sCC VS fCC), while broadening the mutation spectrum and frequency of genes responsible for CC.
Discussion
Approximately 70% of CC cases may occur alone, and 15% of such cases may be accompanied by other ocular abnormalities, such as microphthalmia, aniridia, or retinal degeneration. In another 15% of cases, cataracts are one part of a multisystem genetic disorder [
47]. To obtain clues related to the noncataractous phenotype, we designed a panel with exon-capture and NGS targeting of the 792 genes most frequently involved in common inherited eye diseases. Compared to related previous studies, our study included the largest numbers of patients and targeted genes. We achieved detection rates in familial and sporadic cases similar to those in a recent study [
37]. Although the overall detection rate (45.3%) in our cohort was apparently lower than that in the other studies listed in Table
4, these rates are not comparable due to differences in the proportions of participants. Most of the studies [
17‐
19] included only binocular cataracts, whereas we enrolled many monocular cases. Regarding the distribution of genes, our result was slightly different from those reported previously. Li et al. [
37] reported that variants in the crystallin genes were the most frequent mutations found in their study, whether in familial or sporadic cases. We found that variants in crystallins accounted for a similar proportion of fCC cases but only 1 sCC case (Fig.
1). X-linked syndromic proteins and structural protein genes, such as transmembrane and collagen-associated proteins, accounted for most of the sCCs in our study.
Table. 4
Studies related to the mutation spectrum of CC obtained using NGS in the past 5 years
Target genes | 792 inherited eye diseases | 80 cataract-associated genes | 115 genes associated with CC | 32 cataract -associated genes | 54 cataract-associated genes |
Detection rate | Familial, 87.5% sporadic, 27.03% | familial, 75% sporadic, 47.8% | 70% | 70% | 62.96% |
Participants | 38 sporadic and 16 familial cases, 42 bilateral and 12 unilateral | 23 sporadic and 16 familial cases, all bilateral | 15 sporadic and 21 familial cases all bilateral 16 syndromic | 24 sporadic and 22 familial cases all bilateral nonsyndromic | 25 familial and 2 sporadic |
In our study, approximately 17/27 (62.96%) variants provided clues regarding the possibility of complication with inherited ocular or systemic diseases other than CC. Among these, nine identified loci provided additional ophthalmological diagnostic information. For instance,
OPA3 mutations are associated with optic atrophy [
24],
BEST1 mutations are associated with best vitelliform macular dystrophy (BEST) [
27‐
30],
TSPAN12 mutations are associated with familial exudative vitreoretinopathy (FEVR) [
35],
PAX6 mutation are associated with aniridia and Peter’s anomaly [
48], and
CYP1B1 mutations are associated with glaucoma [
45]. In addition, we also identified a monoallelic mutation in
BMP4, which has been mostly associated with microphthalmia [
40] or facial clefts [
49]. Eight variants were associated with systemic syndrome.
WFS1 is the most common causative gene in Wolfram-like syndrome, a rare autosomal dominant disease characterized by congenital progressive hearing loss, diabetes mellitus, and optic atrophy [
50].
COL4A5 is one of the causative genes in Alport Syndrome, a genetic condition characterized by progressive loss of kidney function, hearing, and eye abnormalities, including misshapen lenses and abnormal retina [
34].
JAG1 has been associated with Alagille syndrome, which involves cholestasis, cardiac defects, ocular abnormalities, skeletal abnormalities and characteristic faces. Loss-of-function mutations in the
BCOR gene have been identified in individuals with oculo-facio-cardio-dental syndrome (OFCD), which includes microcornea, CC, and facial, cardiac, and dental abnormalities [
38]. Mutations in the
FBN1 (fibrillin-1) gene may be diagnostic of Marfan syndrome [
46].
NHS mutations have been identified in patients with Nance-Horan syndrome (NHS), an X-linked developmental disorder characterized by CC, dental anomalies, facial dysmorphism and, in some cases, mental retardation [
51]. Clinically, a new diagnosis was made after surgery and with reference to genetic testing in at least two patients in our cohort. One of the sporadic cases (ID 10 in Table
2) presented some retinal abnormalities during operations after the removal of cataracts in both eyes, including settled subretinal exudates and dragging of the optic disc. Combined with this clinical manifestation, we have clarified the diagnosis of FEVR with regard for the
TSPAN12 mutation, which is a pathogenic gene known to indicate FEVR. We also observed dental, facial and mental anomalies and made a new diagnosis of NHS at 2 years after the first CC operation was performed in one of the sporadic cases with an identified
NHS mutation (ID 6 in Table
2). However, whether other variants are associated with a noncataractous phenotype is difficult to confirm. For example, in family 3 (Table
2), we cannot clearly ascribe one of these variants,
OPA3 or
JAG1 to a cataractogenic effect. It is possible that one or more gene mutations cause multiple eye abnormalities at the same time, and cataracts are only one of the first manifestations found in the clinic. During the follow-up period after cataract surgery, we will pay more attention to whether the child tends to experience optic atrophy and will give suggestions for monitoring liver and cardiac function. The relationships between complicated phenotypes and mutations in ocular genes are not explicit. Thus, more cases should be included, and more experiments should be performed to verify these connections.
It is worth emphasizing that those identified variants in non-classical cataract genes may not be initially ascribed to a cataractogenic effect. They might indicate other inherited eye disorders or syndromes, in which a cataractous phenotype may not be presented in every carrier. Another possibility was that the exact cataractous causative genes are located in regions that have not yet been detected, or even that the cataractous phenotype was not caused by genetic factors at all or may involve epigenetic factors.
The phenomenon in which identified heterozygous variants are also present in unaffected parents in sporadic cases (Table
2) might be explained by incomplete and variable penetrance; the underlying mechanisms of this phenomenon remain largely unknown. A recent study also provides support showing that variants associated with inherited eye disorders are frequently encountered in unaffected individuals and that one in six genes implicated in inherited eye disorders are potentially associated with variable penetrance [
52]. The number of variants and genes that do not segregate (Table
2) is relatively high in our study. Some of these genes, such as
BEST1 and
WFS1, were shown to exhibit variable penetrance in a previous study [
50]. Incomplete penetrance of the remaining genes might not be supported by sufficient evidence, or these genes might not be the causative genes. This phenomenon might also be due to the limited number of samples detected. In a future study, we will continue to expand the sample size, collect more samples of family members, and improve the history tracking. We believe that the proportion of this phenomenon will be significantly reduced.
This study emphasizes the power and necessity for trio NGS analyses of CC families. By identifying pathogenic heterozygous and homozygous mutations, de novo mutations, and parental mosaicism, such analyses may reveal a new pattern of inheritance in CC with significance not limited to the affected child. However, trio NGS can reveal numerous VUS, for which functional validation is mandatory, although it is still a challenge. Furthermore, future research is required to determine the clinical significance of non-Mendelian inheritance, the intricate mutual effect between genetic predispositions and environmental factors, and interactions between genetic and epigenetic. These studies will provide important insights into the pathogenesis and the complex genotype-to-phenotype association of CC. In the future, these results may also lead to the development of novel gene therapies for some types of congenital cataracts, similar to other inherited eye diseases.
A limitation of this study is that samples in which no mutations were identified could be further submitted to whole-genome sequencing but rarely are because it is challenging to obtain a sufficient amount of blood from infants and young children to meet experimental needs.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.